| 2024/06/24 17:30:00 | |
|---|---|
| Price | |
| 41.9675 USD | |
| Difference | 2.25% (0.92) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | London Stock Exchange European Trade Reporting |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 79,765 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 39.87 USD (1,000) |
| Ask (Ask size) | 44.065 USD (1,000) |
| Open | 41.9675 USD |
| High | 41.9675 USD |
| Low | 41.9675 USD |
| Close (prev. day) | 41.045 USD |
| VWAP | 41.567647 USD |
| Volume (pcs) | 1,863 |
| Trading volume | - |
| Number of trades | 7 |
| Last size | - |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/06/24 17:30:00 | |
|---|---|
| Price | |
| 41.9675 USD | |
| Difference | 2.25% (0.92) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | London Stock Exchange European Trade Reporting |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 79,765 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 39.87 USD (1,000) |
| Ask (Ask size) | 44.065 USD (1,000) |
| Open | 41.9675 USD |
| High | 41.9675 USD |
| Low | 41.9675 USD |
| Close (prev. day) | 41.045 USD |
| VWAP | 41.567647 USD |
| Volume (pcs) | 1,863 |
| Trading volume | - |
| Number of trades | 7 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -17.83% | -35.88% | -35.68% |
| Perf (abs.) | -9.11 | -23.48 | -23.28 |
| Beta | 0.33 | 0.50 | 0.31 |
| Volatility | 21.68 | 21.09 | 21.66 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 41.0925 USD (393) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 42.0810 USD (33,728) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 47.4870 USD (11,954) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 52.6966 USD (6,284) |
| YTD High | date | 54.5000 USD (2024/03/12) |
| YTD Low | date | 40.1450 USD (2024/05/30) |
| 52 Weeks High | date | 65.2200 USD (2023/07/24) |
| 52 Weeks Low | date | 40.1450 USD (2024/05/30) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/06/24 | 08:02 | 39.175 EUR | 0.00 | 3 |
| Duesseldorf | 2024/06/24 | 19:30 | 39.185 EUR | 0.00 | 5 |
| Euronext Milan MTF Global Equity Market | 2024/06/24 | 17:44 | 39.025 EUR | 0.00 | 1 |
| Euronext Milan MTF Trading After Hours | 2024/06/03 | 18:00 | 38.58 EUR | 0.00 | 1 |
| Frankfurt | 2024/06/24 | 11:08 | 39.375 EUR | 0.01 | 1 |
| Hamburg | 2024/06/24 | 08:07 | 39.295 EUR | 0.00 | 1 |
| Hanover | 2024/06/24 | 08:00 | 39.18 EUR | 0.00 | 3 |
| London Stock Exchange European Trade Reporting | 2024/06/24 | 17:30 | 41.9675 USD | 0.00 | 7 |
| Munich | 2024/06/24 | 08:02 | 39.175 EUR | 0.00 | 2 |
| NYSE | 2024/06/24 | 22:00 | 42.23 USD | 625.89 | 88,663 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| Stuttgart | 2024/06/24 | 19:30 | 39.215 EUR | 0.04 | 11 |
| Tradegate | 2024/06/25 | 08:00 | 39.475 EUR | 0.00 | 1 |
| Vienna Stock Exchange | 2024/06/24 | 17:32 | 39.195 EUR | 0.00 | 2 |
| Xetra | 2024/06/24 | 17:35 | 39.165 EUR | 0.17 | 70 |
Company Logo
Contact Details
| BRISTOL MYERS SQUIBB CO. |
| - - |
| Route 206 & Province Line Road - 08543 Princeton |
| Telefon: +1-609-252-4621 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Members of Management Board
| Deepak Bhatt | Member of Board of Directors |
| Julia Haller | Member of Board of Directors |
| Karen Vousden | Member of Board of Directors |
| Manuel Hidalgo Medina | Member of Board of Directors |
| Derica Rice | Member of Board of Directors |
| Paula Price | Member of Board of Directors |
| Peter Arduini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Theodore Samuels | Member of Board of Directors |
| Chris Boerner | Chairman of Managing Board |
| Adam Lenkowsky | Member of Executive Committee |
| Amanda Poole | Member of Executive Committee |
| Cari Gallman | Member of Executive Committee |
| David Elkins | Member of Executive Committee |
| Greg Meyers | Member of Executive Committee |
| Karin Shanahan | Member of Executive Committee |
| Kim Jablonski | Member of Executive Committee |
| Lynelle B. Hoch | Member of Executive Committee |
| Pamela Fisher | Member of Executive Committee |
| Peter S. Paine III | Member of Executive Committee |
| Robert Plenge | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Sandra Leung | Member of Executive Committee |